Udaya S. Rangaswamy

发表

A T-cell engaging bispecific antibody with a tumor-selective bivalent folate receptor alpha binding arm for the treatment of ovarian cancer

Harbani K. Malik-Chaudhry, A. Boudreau, N. Trinklein, 2022, Oncoimmunology.

Evaluation of Newcastle disease virus mediated dendritic cell activation and cross‐priming tumor‐specific immune responses ex vivo

H. Jin, Weijia Wang, Qi Xu, 2019, International journal of cancer.

Murine Gammaherpesvirus M2 Protein Induction of IRF4 via the NFAT Pathway Leads to IL-10 Expression in B Cells

S. Speck, Udaya S. Rangaswamy, 2014, PLoS pathogens.

Murine Gammaherpesvirus 68 Reactivation from B Cells Requires IRF4 but Not XBP-1

S. Speck, N. Iwakoshi, B. Wakeman, 2014, Journal of Virology.

Newcastle Disease Virus Establishes Persistent Infection in Tumor Cells In Vitro: Contribution of the Cleavage Site of Fusion Protein and Second Sialic Acid Binding Site of Hemagglutinin-Neuraminidase

P. McTamney, H. Jin, Weijia Wang, 2017, Journal of Virology.

Blimp-1-Dependent Plasma Cell Differentiation Is Required for Efficient Maintenance of Murine Gammaherpesvirus Latency and Antiviral Antibody Responses

S. Speck, Udaya S Rangaswamy, Ruth J. Napier, 2009, Journal of Virology.

Sequence-Based Discovery Demonstrates That Fixed Light Chain Human Transgenic Rats Produce a Diverse Repertoire of Antigen-Specific Antibodies

Michael J. Osborn, A. Boudreau, N. Trinklein, 2018, Frontiers in Immunology.

Antibacterial Monoclonal Antibodies Do Not Disrupt the Intestinal Microbiome or Its Function

D. Tabor, Hui Liu, A. Tovchigrechko, 2020, Antimicrobial Agents and Chemotherapy.

TNB-486 induces potent tumor cell cytotoxicity coupled with low cytokine release in preclinical models of B-NHL

Harbani K. Malik-Chaudhry, A. Boudreau, N. Trinklein, 2021, mAbs.

CD55 is a key complement regulatory protein that counteracts complement-mediated inactivation of Newcastle Disease Virus.

H. Jin, C. Cotter, Zhongying Chen, 2016, The Journal of general virology.

CD 55 is a key complement regulatory protein that counteracts complement-mediated inactivation of Newcastle Disease Virus

H. Jin, C. Cotter, Zhongying Chen, 2016 .

Efficient tumor killing and minimal cytokine release with novel T-cell agonist bispecific antibodies

A. Boudreau, N. Trinklein, O. Vafa, 2019, mAbs.

A bispecific antibody agonist of the IL-2 heterodimeric receptor preferentially promotes in vivo expansion of CD8 and NK cells

Harbani K. Malik-Chaudhry, A. Boudreau, N. Trinklein, 2021, Scientific Reports.

Pre-clinical development of TNB-383B, a fully human T-cell engaging bispecific antibody targeting BCMA for the treatment of multiple myeloma.

N. Trinklein, S. F. Aldred, Duy Pham, 2018 .

VEPAD - Predicting the effect of variants associated with Alzheimer's disease using machine learning

M Michael Gromiha, Uday Rangaswamy, S Akila Parvathy Dharshini, 2020, Comput. Biol. Medicine.

Tyrosine 129 of the Murine Gammaherpesvirus M2 Protein Is Critical for M2 Function In Vivo

S. Speck, Udaya S. Rangaswamy, Brigid M. O’Flaherty, 2014, PloS one.

Development of a fully human t-cell engaging bispecific antibody for the treatment of multiple myeloma.

N. Trinklein, S. F. Aldred, Duy Pham, 2017 .

TNB-486, a Novel Fully Human Bispecific CD19 x CD3 Antibody That Kills CD19-Positive Tumor Cells with Minimal Cytokine Secretion

A. Boudreau, N. Trinklein, S. F. Aldred, 2019, Blood.

Multispecific antibodies targeting CD38 show potent tumor-specific cytotoxicity.

A. Boudreau, N. Trinklein, S. F. Aldred, 2018 .